Mattia Arrigo
Overview
Explore the profile of Mattia Arrigo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
1282
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Myhre P, Grupper A, Mebazaa A, Davison B, Edwards C, Takagi K, et al.
JACC Adv
. 2025 Feb;
4(3):101607.
PMID: 39983609
Background: Elevated alanine aminotransferase (ALT), aspartate aminotransferase (AST), and total bilirubin (tBil) may reflect congestion and liver dysfunction in acute heart failure (AHF), while lower ALT also associates with sarcopenia....
3.
Damasceno A, Saidu H, Cotter G, Davison B, Edwards C, Celutkiene J, et al.
ESC Heart Fail
. 2025 Feb;
PMID: 39938529
Aims: Acute heart failure (AHF) impacts millions globally, with outcomes varying based on socio-economic status (SES). Methods: SES measured by annual household income, years of education and medical insurance coverage....
4.
Oppliger A, Meyer Sauteur P, Dahmen R, Schibli A, Feil B, Arrigo M, et al.
Chest
. 2024 Nov;
166(5):e141-e145.
PMID: 39521548
A 54-year-old Egyptian man with a 5-day history of worsening cough, high-grade fever, and progressive dyspnea was referred to our hospital. A 3-day course of ceftriaxone provided in an outpatient...
5.
Paul M, Eggerschwiler A, Meyer G, Studer C, Hurlimann U, Brandle M, et al.
Swiss Med Wkly
. 2024 Oct;
154:4000.
PMID: 39465325
Diabetes is a well-recognised risk factor for the development of heart failure, with a prevalence higher than 30% in patients with diabetes aged over 60 years. Heart failure often emerges...
6.
7.
Celutkiene J, cerlinskaite-Bajore K, Cotter G, Edwards C, Adamo M, Arrigo M, et al.
Clin Res Cardiol
. 2024 Sep;
113(11):1589-1603.
PMID: 39259364
Background: Anemia is one of the most frequent comorbidities in patients with heart failure (HF), which potentially can interfere with the effect of guideline-recommended HF medical therapy and can be...
8.
Baumberger J, Dinges S, Lupi E, Wolters T, Stussi-Helbling M, Cippa P, et al.
ESC Heart Fail
. 2024 Sep;
12(1):688-694.
PMID: 39239801
Aims: Diuretic resistance (i.e., insufficient diuretic and natriuretic response to an appropriate dose of intravenously administered loop diuretic) is a major cause of insufficient decongestion in acute heart failure (AHF)....
9.
Wenzl F, Wang P, Arrigo M, Parenica J, Jones D, Bruno F, et al.
Eur Heart J
. 2024 Aug;
46(1):38-54.
PMID: 39215600
Background And Aims: Circulating proenkephalin (PENK) is a stable endogenous polypeptide with fast response to glomerular dysfunction and tubular damage. This study examined the predictive value of PENK for renal...
10.
Biegus J, Mebazaa A, Davison B, Cotter G, Edwards C, Celutkiene J, et al.
J Am Coll Cardiol
. 2024 Jul;
84(4):323-336.
PMID: 39019527
Background: Comprehensive uptitration of neurohormonal blockade targets fundamental mechanisms underlying development of congestion and may be an additional approach for decongestion after acute heart failure (AHF). Objectives: This hypothesis was...